Half-year Report

Source: RNS
RNS Number : 3583X
Amedeo Air Four Plus Limited
20 December 2023
 

20 December 2023

 

AMEDEO AIR FOUR PLUS LIMITED (the "Company")

(LSE: AA4, LEI: 21380056PDNOTWERG107)

 

HALF-YEARLY FINANCIAL REPORT

 

The Board of the Company is pleased to announce its results for the period from 1 April 2023 to 30 September 2023.

 

To view the Company's half-yearly financial report please follow the link below:

 

http://www.rns-pdf.londonstockexchange.com/rns/3583X_1-2023-12-19.pdf

 

The half-yearly financial report will also shortly be available on the Company's website http://www.aa4plus.gg

 

The Company's half-yearly financial report will be submitted to the National Storage Mechanism in accordance with Listing Rule 9.6.1 and available for inspection in unedited full text at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

This announcement is made in accordance with DTR 6.3.5R(1A).

 

For further information, please contact:

 

JTC Fund Solutions (Guernsey) Limited

 

+44 (0) 1481 702 400


Liberum Capital Limited

 

Chris Clarke / Darren Vickers / Owen Matthews

+44 (0) 20 3100 2000

 

About the Company

 

The Company is a Guernsey-domiciled company, with shares admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market (LSE: AA4).

 

The Company's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BIBDDSDBDGXC